IgA nephropathy: open trials in France

• NCT06963827

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  Trial Treatment · Phase 3 · Takeda

  Centre hospitalier Universitaire de Bordeaux, Bordeaux · Assistance Publique Hopitaux De Paris, Creteil · Centre Hospitalier Et Universitaire de Limoges, Limoges · Centre Hospitalier Universitaire de Montpellier, Montpellier · Centre Hospitalier Universitaire de Nantes, Nantes · Assistance Publique Hopitaux de Paris, Paris

  Registry updated 2026-11-04

• 2024-519638-22-00

  A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Cedex 9 · Centre Hospitalier Universitaire de Lille, Lille · Hospices Civils De Lyon, Lyon Cedex 03 · Assistance Publique Hopitaux de Paris, Paris

  Registry updated 2026-10-30

• NCT07498335

  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Bron · Nantes · Toulouse

  Registry updated 2026-10-15

• NCT06935357

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Trial Treatment · Phase 3 · Biogen

  Centre Hospitalier Universitaire Amiens Picardie, Amiens Cedex 1 · CHU Besançon, Besançon · Centre hospitalier Universitaire de Bordeaux, Bordeaux · Assistance Publique Hopitaux De Paris, Creteil Cedex · Centre Hospitalier Departemental Vendee, La Roche Sur Yon Cedex 9 · Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse · Centre Hospitalier Universitaire De Nimes, Nimes Cedex 9 · Centre Hospitalier Universitaire D Orleans, Orleans Cedex 2 · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Universitaire Reims, Reims · Les Hopitaux Universitaires de Strasbourg, Strasbourg · Hospital Foch, Suresnes

  Registry updated 2026-10-14

• NCT06350630

  Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

  Trial Treatment · Phase 2 · Centre Hospitalier Universitaire de Saint Etienne

  Centre hospitalier Universitaire de Bordeaux, Bordeaux · Chu Gabriel Montpied, Clermont-Ferrand · Centre Hospitalier Annecy Genevois, Epagny Metz-tessy · Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Cedex 9 · Centre Hospitalier Et Universitaire de Limoges, Limoges · Hospital Edouard Herriot, Lyon Cedex 03 · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Universitaire De Nimes, Nimes Cedex 9 · Assistance Publique Hopitaux de Paris, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 18 · Hopital Tenon, Paris Cedex 20 · Hospices Civils de Lyon, Pierre-Bénite · Centre Hospitalier Universitaire de Rennes, Rennes · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex · Centre Hospital Region Metz Thionville, Thionville · Centre Hospitalier de Valenciennes, Valenciennes

  Registry updated 2026-10-09

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Assistance Publique Hopitaux de Paris, Paris

  Registry updated 2026-10-05

• NCT05234463

  Study of the Link Between Complement Activation and IgA Nephropathy Severity

  Research · University Hospital, Strasbourg, France

  Service de néphrologie, Strasbourg

  Registry updated 2026-08-19

• NCT07010250

  Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

  Research · Assistance Publique - Hôpitaux de Paris

  Georges-Pompidou European Hospital, AP-HP, Paris

  Registry updated 2026-06-30

• NCT06926244

  RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

  Research · Assistance Publique - Hôpitaux de Paris

  Nephrology department, Hospital Pitié - Salpêtrière (ASSISTANCE PUBLIQUE HOPITAUX DE PARIS AP-HP), Paris

  Registry updated 2026-06-23

• NCT07295808

  Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)

  Trial Treatment · University Hospital, Limoges

  CHU Limoges, Limoges

  Registry updated 2025-12-22

• NCT05791162

  Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy

  Trial Treatment · Centre Hospitalier Universitaire de Besancon

  Centre Hospitalier Universitaire de Besançon, Besançon

  Registry updated 2024-11-21

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error